HOLX News and Press, Hologic Inc. From 05/17/22

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

--The 16th Annual List Recognizes the Most Influential Corporate Directors and Governance Experts-- Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, announced today that Board of Director's member, Sally W. Crawford, has been recognized by the Nation...

Healthcare equipment and Medical Devices sector stood out during the covid-19 pandemic crisis and delivered strong returns over the medium and long term. Stocks from healthcare equipment and Medical Devices sector have performed poorly over the past one month, resulting in steep price...

-- Hologic’s first quantitative test for transplant pathogen monitoring standardizes clinical information to help enhance patient outcomes -- Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) approved its Aptima CMV Quant as...

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the following upcoming investor conferences: Bank of America 2022 Healthcare Conference on Tuesday, May 10 at 8:00 a.m. Pacific Time William Blair 42 nd Annual Growth Stock Conference on Tuesday,...

The management team at Insulet Corporation is due to report financial data for the first quarter of the company's 2022 fiscal year. Growth should come in strong, just as it has in prior years, and the long-term outlook for Insulet looks favorable. But PODD shares are far too price...

Kahn Brothers’ 13F portfolio value increased from $741M to $788M this quarter. Citigroup, ViewRay, and VOXX International were increased during the quarter. The portfolio continues to be very concentrated with the top five positions accounting for ~48% of the 13F holdings. ...

Health equipment maker Hologic (NASDAQ:HOLX) is trading lower for the six straight session in morning hoursThursday despite reporting better than expected financials for 2Q fiscal 2022. Revenue for the quarter reached ~$1.4B to exceed forecasts by $150M even after ~7% YoY decline, and the com...

Hologic, Inc. (HOLX) Q2 2022 Earnings Conference Call April 27, 2022 16:30 ET Company Participants Ryan Simon - Vice President, Investor Relations Steve MacMillan - Chairman, President and Chief Executive Officer Karleen Oberton - Chief Financial Officer Conference Call Participants Jack Meeh...

Image source: The Motley Fool. Hologic (NASDAQ: HOLX) Q2 2022 Earnings Call Apr 27, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Hologic (HOLX) Q2 2022 Earnings Call Transcript